CrushSCI.com
提供学术论文选刊润色服务
Dermatologic Therapy 期刊封面 医学
返回期刊列表

Review Cycle Records

Dermatologic Therapy

Hindawi / Wiley SCIE 非OA
2026新锐 3区2025中科院 3区2025 JCR Q1
214.7平均天数
156中位天数
31最短天数
519最长天数
1212025发文量

Paper Review Records

全部论文审稿周期

11 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

101 天

Oxymatrine‐Associated Clinical and Molecular Changes in Psoriasis: An Exploratory WGCNA‐Based Translational Study

作者Wenfei Luo; Wenbo Cai; Yangxu Ding; Huijuan Shi

作者单位1. Ningxia Medical University; 2. Ningxia Medical University General Hospital

PDF源文件 DOI 网页
99 天

Biologic Therapy for Refractory Pityriasis Rubra Pilaris

作者Chenmei Liu; Freddy Gahimbare; Junfen Zhang; Bin Yang

作者单位1. Southern Medical University

PDF源文件 DOI 网页
31 天

Prevalence and Systemic Manifestations of PHACE Syndrome: A Systematic Review and Meta‐Analysis

作者Yunyan Han; Kaizhi Zhang; Zixin Zhang; Tong Qiu; J Zhou; Zilong Zhou; Yuru Lan; Yi Ji

作者单位1. Sichuan University; 2. West China Hospital of Sichuan University

PDF源文件 DOI 网页
371 天

Smoking and Nail Psoriasis: Examining the Connection in a Case‐Control Study

作者Safoura Shakoei; Fatemeh Heidari; Maryam Nasimi; Shahin Hamzelou; Fatemeh Saberi; Hanie Babaie

作者单位1. Imam Khomeini Hospital; 2. Razi Hospital; 3. Tehran University of Medical Sciences

PDF源文件 DOI 网页
156 天

Dermoscopic Differentiation of Actinic Keratosis and Bowen’s Disease: A Model for Challenging Facial High‐Grade Lesions

作者Li Tang; Yong Ai; H. Shi; Y Q Wu; Xianwei Cao; Xiaohua Tao; Lifang Cheng; Pingxiu He; Zhenhua Zhang; Xuran Zhang; Wenbin Rao; Chun Huang; Xiaobing Wang

作者单位1. Nanchang University; 2. First Affiliated Hospital of Jiangxi Medical College; 3. Jiangxi Chest Hospital; 4. JiangSu Armed Police General Hospital; 5. First Affiliated Hospital of Nanchang University; 6. Jiangxi Provincial People's Hospital

PDF源文件 DOI 网页
343 天

Dupilumab Efficacy and Safety Among Different Ages and Age of Onset of Atopic Dermatitis: Real‐World Experience

作者Noha Mohammed Dawoud; Rogaiah Zuhair Sagr; Ahmed Mohammed Bin Mahfoz; Amany Mohammed El-Rebigi

作者单位1. Armed Forces Hospital; 2. Menoufia University; 3. Benha University

PDF源文件 DOI 网页
94 天

Skin‐Protective Effects of DeinoPol‐BRD125, a Microbial Exopolysaccharide From Deinococcus radiodurans , on Epidermal Hydration and Barrier Recovery

作者Ki Bum Ahn; Hyun Jung Ji; Sun-Young Kim; Yeongkag Kwon; M Kim; Ho Seong Seo; Hae‐Ran Park

作者单位1. Korea Atomic Energy Research Institute; 2. Seoul National University; 3. National University College; 4. Daejeon Institute of Science and Technology; 5. Korea University of Science and Technology

PDF源文件 DOI 网页
72 天

Dermoscopy in the Treatment Monitoring of Cutaneous Infectious Diseases: A Review

作者Andrea Calogero Trecarichi; Giuseppe Micali; Anna Elisa Verzì

作者单位1. University of Catania

PDF源文件 DOI 网页
352 天

Oat β‐Glucan Improves Skin Barrier Repair by Regulating EGFR Signaling Pathway

作者Xiaolong Jiang; Simin Wu; Shaolin Hong; Hankun Ren; Yinmao Dong; Yuhong Liu

作者单位1. Beijing Biocytogen (China); 2. Beijing Academy of TCM Beauty Supplements Co., Ltd. , Beijing , 102401 , China; 3. American Academy of Cosmetic Surgery; 4. Beijing Technology and Business University

PDF源文件 DOI 网页
224 天

Advances in Atopic Dermatitis Management: The Role of Lebrikizumab

作者Saba Mushtaq; Hafsa Shuja; Hamza Yousuf Ibrahim; Syeda Farwa Zehra; Umer Wamiq; Muhammad Faisal; Fawaz ur Rehman; Ayesha Abdullah; Ehsanullah Alokozay

作者单位1. Ayub Medical College; 2. Jinnah Sindh Medical University; 3. Jinnah Medical & Dental College; 4. Gomal University; 5. Khyber Medical University; 6. Dow University of Health Sciences; 7. Kandahar University

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。